Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sarepta Therapeutics Inc
SRPT
Healthcare
Biotechnology
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy...
(Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. It has developed and commercialized four approved products for the treatment of Duchenne: EXONDYS 51 (eteplirsen), Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53), AMONDYS 45 (casimersen) Injection (AMONDYS 45), and ELEVIDYS. Its pipeline includes approximately 40 programs at various stages of discovery, pre-clinical and clinical development.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SRPT)
New Post
View:
Posts & Comments
Threaded Posts
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 03, 2024 6:24am
Sarepta Therapeutics (NASDAQ:SRPT): Analysis of Financial Pe
https://beyondspx.com/2024/08/02/sarepta-therapeutics-nasdaqsrpt-analysis-of-financial-performance-and-pipeline-progress/
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 21, 2024 10:45am
Buy Recommendation Issued On SRPT By Needham
JUST IN: $SRPT Buy Recommendation Issued On SRPT By Needham2024-06-21 10:15:03 ET Needham analyst issues BUY recommendation for SRPT on June 21, 2024 08:32AM ET. The previous analyst recommendation
...more
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 21, 2024 10:30am
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystro
NEWS: $SRPT FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy | BenzingaThursday, the FDA approved labeled indication for Sarepta Therapeutics Inc@s (NASDAQ:SRPT
...more
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 16, 2024 3:00pm
Why Sarepta Therapeutics Stock Is Soaring Today
News; $SRPT Why Sarepta Therapeutics Stock Is Soaring Today2024-02-16 11:23:56 ET Shares of Sarepta Therapeutics (NASDAQ: SRPT) were soaring 10.4% higher as of 10:58 a.m. ET on Friday. The big gain
...more
(6066)
•••
tamaracktop
X
View Profile
View Bullboard History
Comment by
tamaracktop
on Jan 07, 2021 5:58pm
RE:Don't sweat today's trading people
Sincere appologies. Wrong board.
(6066)
•••
tamaracktop
X
View Profile
View Bullboard History
Post by
tamaracktop
on Jan 07, 2021 5:50pm
Don't sweat today's trading people
In marketland, today is already yesterday. Yesterday is history Tomorrow's a mystery Today is a gift from God That's why they call it The Present After today, Xebec is a present. A "
...more
(3)
•••
Mil_Man54
X
View Profile
View Bullboard History
Post by
Mil_Man54
on Dec 01, 2020 10:09am
Bonvoyage12....Pathetic Pumper
This pumper spams multiple boards with paid PR BS......depserately trying to promote losing stocks....ignore him and report him.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >